QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 tonix-pharmaceuticals-ceo-highlights-tnx-1500-progress-and-anti-cd154-therapy-in-organ-transplantation-at-japan-conference

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) ("Tonix" or the "Company"), a fully integrated biotechnology ...

 tonix-pharma-plans-to-progress-tnx-2900-program-for-treatment-of-pws-into-phase-2-clinical-trial

Phase 2 randomized, double-blind, placebo-controlled trial planned to evaluate TNX-2900 in children and adolescents (ages 8 to ...

 tonix-pharmaceuticals-completes-type-b-pre-ind-meeting-with-fda-for-tnx-102-sl-for-treatment-of-major-depressive-disorder

Tonix anticipates filing the IND application in the fourth quarter of 2025TNX-102 SL is a potential first-in-class treatment fo...

 tonix-pharmaceuticals-announces-in-licensing-of-tnx-4800-monoclonal-antibody-for-annual-lyme-disease-prevention-across-us-endemic-regions

Positive Phase 1 study showed safety, tolerability and a linear pharmacokinetic: pharmacodynamic: efficacy relationship (1: 1: ...

 tonix-presents-clinical-data-on-tonmya-for-treatment-of-fibromyalgia-at-painweek-conference-2025-phase-3-data-support-q4-launch-following-painweek-showcase

Tonmya was approved by FDA on August 15, 2025 for the treatment of fibromyalgia and is the first new FDA approved treatment for...

 tonix-pharmas-drug-gets-fda-nod-for-chronic-pain-condition-first-new-therapy-in-over-15-years

FDA approves Tonmya, a non-opioid fibromyalgia therapy from Tonix, with strong trial data and U.S. launch expected in late 2025.

 fda-approves-tonix-pharmas-tonmya-for-treatment-of-fibromyalgia-in-adults

Tonmya is the first FDA-approved therapy for the treatment of fibromyalgia in over 15 yearsFibromyalgia is a chronic pain condi...

 whats-going-on-with-tonix-pharmaceuticals-tnxp-stock

Shares of Tonix Pharmaceuticals have rallied 30% over the past five sessions. Investors are anticipating a key catalyst for the...

 why-tonix-pharmaceuticals-tnxp-stock-is-climbing-this-week

Shares of Tonix Pharmaceuticals are building on recent gains. The stock is trading higher as investor focus intensifies on a ke...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION